{
    "root": "2f8663a1-6d47-1d0e-e063-6394a90ac57f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "mycophenolate mofetil",
    "value": "20250304",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "POVIDONE K90",
            "code": "RDH86HJV5Z"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "MYCOPHENOLATE MOFETIL",
            "code": "9242ECW6R0"
        }
    ],
    "indications": "mycophenolate mofetil ( mmf ) indicated prophylaxis organ rejection , adult pediatric recipients 3 months age older allogeneic kidney [ ( 14.1 ) ] , heart [ ( 14.2 ) ] liver transplants [ ( 14.3 ) ] , combination immunosuppressants .",
    "contraindications": "adults kidney transplant 1g twice daily , orally intravenously ( iv ) less 2h ( 2.2 ) heart transplant 1.5 g twice daily orally iv , less 2 h ( 2.3 ) liver transplant 1.5 g twice daily orally 1 g twice daily iv less 2 h ( 2.4 ) pediatrics kidney transplant 600mg/m 2 orally twice daily , maximum 2 g daily ( 2.2 ) heart transplant 600 mg/m 2 orally twice daily ( starting dose ) maximum 900 mg/m 2 twice daily ( 3 g 15 ml oral suspension ) ( 2.3 ) liver transplant 600 mg/m 2 orally twice daily ( starting dose ) maximum 900 mg/m 2 twice daily ( 3 g 15 ml oral suspension ) ( 2.4 ) mycophenolate mofetil intravenous alternative patients tolerate oral medication . administer within 24 hours following transplantation , patients tolerate oral medication , 14 days . ( 2.1 ) reduce interrupt dosing event neutropenia . ( 2.5 ) full prescribing information ( fpi ) : adjustments renal impairment neutropenia ( 2.5 ) , preparation oral suspension iv solution . ( 2.6 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "allergic mycophenolate mofetil observed ; therefore , mycophenolate mofetil contraindicated patients hypersensitivity mycophenolate mofetil ( mmf ) , mycophenolic acid ( mpa ) component product . mycophenolate mofetil intravenous contraindicated patients allergic polysorbate 80 ( tween ) .",
    "indications_original": "Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney\n \n  [see\n  \n   Clinical Studies (14.1)]\n \n  , heart\n \n  [see\n  \n   Clinical Studies (14.2)]\n \n  or liver transplants\n \n  [see\n  \n   Clinical Studies (14.3)]\n \n  , in combination with other immunosuppressants.",
    "contraindications_original": "ADULTS DOSAGE Kidney Transplant 1g twice daily,orally or intravenously (IV) over no less than 2h ( 2.2 ) Heart Transplant 1.5 g twice daily orally or IV, over no less than 2 h ( 2.3 ) Liver Transplant 1.5 g twice daily orally or 1 g twice daily IV over no less than 2 h ( 2.4 ) PEDIATRICS Kidney Transplant 600mg/m 2 orally twice daily, up to maximum of 2 g daily ( 2.2 ) Heart Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (3 g or 15 mL of oral suspension) ( 2.3 ) Liver Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (3 g or 15 mL of oral suspension) ( 2.4 ) Mycophenolate mofetil intravenous is an alternative when patients cannot tolerate oral medication. Administer within 24 hours following transplantation, until patients can tolerate oral medication, up to 14 days. ( 2.1 ) Reduce or interrupt dosing in the event of neutropenia. ( 2.5 ) See full prescribing information (FPI) for: adjustments for renal impairment and neutropenia ( 2.5 ), preparation of oral suspension and IV solution. ( 2.6 )",
    "adverseReactions_original": "Allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil is contraindicated in patients with a hypersensitivity to mycophenolate mofetil (MMF), mycophenolic acid (MPA) or any component of the drug product. Mycophenolate mofetil intravenous is contraindicated in patients who are allergic to Polysorbate 80 (TWEEN)."
}